Gujarat Themis Biosyn Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 476.91 million compared to INR 350.47 million a year ago. Revenue was INR 490.87 million compared to INR 357.61 million a year ago. Net income was INR 186.99 million compared to INR 137.92 million a year ago. Basic earnings per share from continuing operations was INR 2.574 compared to INR 1.898 a year ago.
For the six months, sales was INR 926.35 million compared to INR 674.87 million a year ago. Revenue was INR 954.54 million compared to INR 693.35 million a year ago. Net income was INR 364.69 million compared to INR 267.15 million a year ago. Basic earnings per share from continuing operations was INR 5.02 compared to INR 3.678 a year ago.